体内 K27M 组蛋白突变的功能解析-猫眼课题宝

体内 K27M 组蛋白突变的功能解析

批准号：

9134879

负责人：

Oren Josh Becher

金额：

$4.41万

依托单位：

DUKE UNIVERSITY

依托单位国家：

美国

项目类别：

财政年份：

2014

资助国家：

美国

项目状态：

已结题

起止时间：

2014-09-01 至 2016-12-23

来源：

https://reporter.nih.gov/project-details/9134879

关键词：

Accounting Astrocytes Biology Brain Neoplasms Brain Stem Brain Stem Glioma Brain Stem Neoplasms Cause of Death Cell Proliferation Cells Child Childhood Brain Neoplasm Clinical Trials Complex Development Diffuse intrinsic pontine glioma Disease Dissection Dorsal Foundations Gene Targeting Genes Genetic Genetically Engineered Mouse Glial Fibrillary Acidic Protein Gliomagenesis Goals Health Histone H3.3 Histones Human In Vitro Independent Scientist Award Laboratories Location Malignant Neoplasms Malignant neoplasm of brain Modeling Molecular Profiling Mus Mutation Neonatal Pathogenesis Pharmaceutical Preparations Platelet-Derived Growth Factor Polycomb Proto-Oncogene Proteins c-sis Reporting Research Scientist TP53 gene Therapeutic Agents comparative design differential expression effective therapy gain of function mutation in vivo mouse model mutant nerve stem cell nestin protein novel overexpression progenitor relating to nervous system transcriptome sequencing tumor tumorigenesis

项目摘要

项目成果

Oren Josh Becher的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

DESCRIPTION (provided by applicant): Diffuse Intrinsic Pontine Glioma (DIPG) is an incurable brain tumor that arises in children. My laboratory is one of very few laboratories around the world that is studying DIPG biology using genetically engineered mouse modeling. This Independent Scientist Award will give me the opportunity to focus on research to dissect the mechanisms by which K27M histone mutations contribute to DIPG pathogenesis. Ultimately, this information will lay the groundwork for the identification of effective therapeutic agents to treat this incurable cancer.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文